These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15495442)

  • 1. Proteinuria as a mortality risk.
    Duddleston DN
    J Insur Med; 2004; 36(3):262-6. PubMed ID: 15495442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urine protein/creatinine ratio as a mortality risk predictor in non-diabetics with normal renal function.
    Fulks M; Stout RL; Dolan VF
    J Insur Med; 2012; 43(2):76-83. PubMed ID: 22876411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: The HUNT II Study.
    Hallan S; Astor B; Romundstad S; Aasarød K; Kvenild K; Coresh J
    Arch Intern Med; 2007 Dec; 167(22):2490-6. PubMed ID: 18071172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Subclinical albuminuria, microalbuminuria and proteinuria--accepted cardiovascular risk markers?].
    Schmieder RE; Schrader J; Zidek W; Tebbe U; Bramlage P; Paar WD; Böhm M
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2665-71. PubMed ID: 17109277
    [No Abstract]   [Full Text] [Related]  

  • 5. Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: final results of a prospective long-term study (MARPLE Study)*.
    Schrader J; Lüders S; Kulschewski A; Hammersen F; Züchner C; Venneklaas U; Schrandt G; Schnieders M; Rangoonwala B; Berger J; Dominiak P; Zidek W;
    J Hypertens; 2006 Mar; 24(3):541-8. PubMed ID: 16467658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular risk factors, BMI and mortality in a cohort of Swiss males (1976-2001) with high-sum-assured life insurance cover.
    Baldinger B; Schwarz C; Jaggy C
    J Insur Med; 2006; 38(1):44-53. PubMed ID: 16642642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dipstick urine protein, as a predictor of cardiovascular mortality in Korean men: Korea Medical Insurance Corporation study.
    Ha K; Kim HC; Kang DR; Nam CM; Ahn SV; Suh I
    J Prev Med Public Health; 2006 Sep; 39(5):427-32. PubMed ID: 17076184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of proteinuria as a prognostic marker of mortality and cardiovascular events among patients undergoing percutaneous coronary intervention (data from the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events [EXCITE] trial).
    Mercado N; Brugts JJ; Ix JH; Shlipak MG; Dixon SR; Gersh BJ; Lemos PA; Guarneri M; Teirstein PS; Wijns W; Serruys PW; Boersma E; O'Neill WW
    Am J Cardiol; 2008 Nov; 102(9):1151-5. PubMed ID: 18940282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of outcome in Henoch-Schönlein nephritis in children and adults.
    Coppo R; Andrulli S; Amore A; Gianoglio B; Conti G; Peruzzi L; Locatelli F; Cagnoli L
    Am J Kidney Dis; 2006 Jun; 47(6):993-1003. PubMed ID: 16731294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney disease as a predictor of mortality in chronic spinal cord injury.
    Greenwell MW; Mangold TM; Tolley EA; Wall BM
    Am J Kidney Dis; 2007 Mar; 49(3):383-93. PubMed ID: 17336699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the association between microalbuminuria and the urine albumin-creatinine ratio and systemic disease in dogs.
    Whittemore JC; Gill VL; Jensen WA; Radecki SV; Lappin MR
    J Am Vet Med Assoc; 2006 Sep; 229(6):958-63. PubMed ID: 16978114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for microalbuminuria by use of microproteinuria.
    Khatami Z; McIlveen DW; Nesbitt SG; Young IS
    East Mediterr Health J; 2005 May; 11(3):358-65. PubMed ID: 16602454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the ARKRAY AUTION Eleven reflectometer in detecting microalbuminuria with AUTION Screen test strips and proteinuria with AUTION Sticks 10PA strips.
    Kouri T; Nokelainen P; Pelkonen V; Kosaka H; Saeger B
    Scand J Clin Lab Invest; 2009; 69(1):52-64. PubMed ID: 18923968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microalbuminuria in treated hypertensives: only a mirror image of cardiovascular risk? The HUNT Study, Norway.
    Kvenild K; Romundstad S; Midthjell K; Krüger O; Hallan H; Holmen J
    Scand J Prim Health Care; 2006 Sep; 24(3):145-53. PubMed ID: 16923623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Notes regarding confidence intervals and statistics for standardized mortality ratios and survival curves in the insurance industry.
    Winsemius DK
    J Insur Med; 2006; 38(1):9-13. PubMed ID: 16642638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients with left ventricular hypertrophy and diabetes.
    Ibsen H; Olsen MH; Wachtell K; Borch-Johnsen K; Lindholm LH; Mogensen CE
    J Nephrol; 2008; 21(4):566-9. PubMed ID: 18651547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population.
    Astor BC; Hallan SI; Miller ER; Yeung E; Coresh J
    Am J Epidemiol; 2008 May; 167(10):1226-34. PubMed ID: 18385206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors predicting progression of IgA nephropathies.
    Coppo R; D'Amico G
    J Nephrol; 2005; 18(5):503-12. PubMed ID: 16299675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study.
    Arnlöv J; Evans JC; Meigs JB; Wang TJ; Fox CS; Levy D; Benjamin EJ; D'Agostino RB; Vasan RS
    Circulation; 2005 Aug; 112(7):969-75. PubMed ID: 16087792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial.
    Ishani A; Grandits GA; Grimm RH; Svendsen KH; Collins AJ; Prineas RJ; Neaton JD
    J Am Soc Nephrol; 2006 May; 17(5):1444-52. PubMed ID: 16611715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.